Alexandra J. Lansky, MD — Columbia University Medical Center, Cardiovascular Research Foundation
Faculty Disclosure
Grant and/or Research: Cordis; Johnson & Johnson; Guidant; Conor Medical; Boston Scientific; Medtronic; Biosensors; Bristol Myers Squibb
Learning Objectives
- Review the risks of diabetes mellitus after invasive coronary revascularization
- Understand the ongoing diabetic trials in patients with coronary artery disease
- Examine catheter components and guidewire operation and issues
- Describe risk factors and prevention for contrast induced nephropathy
- Discuss risk assessment in PCI patients